STMMStemcell Hldgs Inc.

About Stemcell Hldgs Inc. (STMM)

Stemcell Hldgs Inc. (STMM) is a N/A company headquartered in New York, NY, United States whose shares trade over-the-counter on the Pink tier.

Stemcell Holdings, Inc. is a holding company that is engaged in the regenerative medicine-related business, which provides technical assistance to the culturing, storing and delivery of stem cells, administrative and consulting services to clinics through its subsidiary, Stemlink, K.K., a Japanese corporation.

Products and services

Stemlink, K.K. specializes in regenerative medicine. Stemlink, K. K. provides a comprehensive suite of services, including consulting, establishment and management of cell culture facilities, and human resource development in the regenerative medicine field. This includes the development and sale of Exosomes. Exosomes are a tiny sac-like structure that is formed inside a cell and contains some of the cell's proteins, DNA, and RNA. They are able to transfer the proteins, DNA, and RNA they contain into other cells. Exosomes may play a role in the spread of cancer and may also keep immune cells from killing cancer cells. Stemlink, K. K. also provides stem cell culture fluid and exosomes as raw materials for skin care and hair care products.

STMM key facts

Ticker symbol

STMM

Market tier

Pink

Headquarters

New York, NY, United States

Country of incorporation

US

Year of incorporation

2015

Employees

10

Estimated market cap

$66.01M (as of May 14, 2025)

Shares outstanding

1,100,088,944

Reporting standard

Alternative Reporting Standard

Audit status

Unaudited

Fiscal year end

12/31

Latest filing

Annual Report (Dec 31, 2024)

Stemcell Hldgs Inc. leadership

• Takayuki Matsuo — CEO, President, CFO

Explore more: Pink stocks · OTC stocks starting with S